Annual Non Current Assets
$1.93 M
-$99.90 K-4.93%
31 December 2023
Summary:
Entero Therapeutics annual long term assets is currently $1.93 million, with the most recent change of -$99.90 thousand (-4.93%) on 31 December 2023. During the last 3 years, it has fallen by -$438.00 thousand (-18.52%). ENTO annual non current assets is now -67.41% below its all-time high of $5.91 million, reached on 01 December 2014.ENTO Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$1.98 M
+$77.90 K+4.10%
01 September 2024
Summary:
Entero Therapeutics quarterly long term assets is currently $1.98 million, with the most recent change of +$77.90 thousand (+4.10%) on 01 September 2024. Over the past year, it has increased by +$51.40 thousand (+2.67%). ENTO quarterly non current assets is now -97.63% below its all-time high of $83.64 million, reached on 31 March 2024.ENTO Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENTO Non Current Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | +2.7% |
3 y3 years | -18.5% | -16.4% |
5 y5 years | -64.9% | -64.0% |
ENTO Non Current Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -18.5% | at low | -97.6% | +4.1% |
5 y | 5 years | -64.9% | at low | -97.6% | +4.1% |
alltime | all time | -67.4% | at low | -97.6% | +4.1% |
Entero Therapeutics Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $1.98 M(+4.1%) |
June 2024 | - | $1.90 M(-97.7%) |
Mar 2024 | - | $83.64 M(+4240.6%) |
Dec 2023 | $4.96 M(+45.2%) | $1.93 M(-1.2%) |
Sept 2023 | - | $1.95 M(-1.2%) |
June 2023 | - | $1.97 M(-1.5%) |
Mar 2023 | - | $2.00 M(-1.1%) |
Dec 2022 | $3.41 M(-63.8%) | - |
Dec 2022 | - | $2.03 M(-3.3%) |
Sept 2022 | - | $2.10 M(-2.0%) |
June 2022 | - | $2.14 M(-6.0%) |
Mar 2022 | - | $2.28 M(-3.8%) |
Dec 2021 | $9.43 M(+19.8%) | $2.37 M(-51.9%) |
Sept 2021 | - | $4.92 M(-4.6%) |
June 2021 | - | $5.16 M(+7.3%) |
Mar 2021 | - | $4.81 M(-4.8%) |
Dec 2020 | $7.87 M | $5.05 M(-2.5%) |
Sept 2020 | - | $5.18 M(-1.5%) |
June 2020 | - | $5.26 M(-0.5%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2020 | - | $5.29 M(-3.8%) |
Dec 2019 | $3.41 M(-29.0%) | $5.49 M(-3.7%) |
Sept 2019 | - | $5.71 M(-4.6%) |
June 2019 | - | $5.98 M(-2.7%) |
Mar 2019 | - | $6.15 M(+130.5%) |
Dec 2018 | $4.80 M(+145.8%) | $2.67 M(-7.8%) |
Sept 2018 | - | $2.90 M(-6.8%) |
June 2018 | - | $3.11 M(-9.8%) |
Mar 2018 | - | $3.44 M(-2.4%) |
Dec 2017 | $1.95 M(-34.1%) | $3.53 M(-3.4%) |
Sept 2017 | - | $3.65 M(-2.2%) |
June 2017 | - | $3.73 M(+1.6%) |
Mar 2017 | - | $3.67 M(-3.1%) |
Dec 2016 | $2.96 M(+43.4%) | $3.79 M(-10.3%) |
Sept 2016 | - | $4.22 M(-2.3%) |
June 2016 | - | $4.32 M(-6.4%) |
Mar 2016 | - | $4.62 M(+0.1%) |
Dec 2015 | $2.07 M(+211.6%) | $4.62 M |
Dec 2014 | $663.50 K | - |
FAQ
- What is Entero Therapeutics annual long term assets?
- What is the all time high annual non current assets for Entero Therapeutics?
- What is Entero Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Entero Therapeutics?
- What is Entero Therapeutics quarterly non current assets year-on-year change?
What is Entero Therapeutics annual long term assets?
The current annual non current assets of ENTO is $1.93 M
What is the all time high annual non current assets for Entero Therapeutics?
Entero Therapeutics all-time high annual long term assets is $5.91 M
What is Entero Therapeutics quarterly long term assets?
The current quarterly non current assets of ENTO is $1.98 M
What is the all time high quarterly non current assets for Entero Therapeutics?
Entero Therapeutics all-time high quarterly long term assets is $83.64 M
What is Entero Therapeutics quarterly non current assets year-on-year change?
Over the past year, ENTO quarterly long term assets has changed by +$51.40 K (+2.67%)